Targeting escape mutations in hematological cancers with first and best in class medicines.
Investors 1
| Date | Name | Website |
| 05.08.2025 | Montrose C... | montroseca... |
Mentions in press and media 1
| Date | Title | Description |
| - | Lomond Therapeutics | “Targeting escape mutations in hematological cancers with first and best in class medicines.” |